Wesley Clark
CIK: 0001349193
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Clark Wesley
Clark Wesley (SEC CIK 0001349193) files insider reports with the SEC as Director of ImmunityBio, Inc. (IBRX) and Director of Blue Acquisition Corp/Cayman (BACC).
Signal8 holds 3 ownership filings by Clark Wesley (1 Form 3, 2 Form 4), filed between Jun 12, 2025 and Jun 10, 2026. Those filings report 2 transactions, from Jun 18, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Clark Wesley's filings is in SAN DIEGO, CA.
Recent filings by Clark Wesley
Other insiders filing for ImmunityBio, Inc. (IBRX)
- Simon Barry J., Director
- Cohen Cheryl, Director
- Selecky Christobel, Director
- BLASZYK MICHAEL D, Director
- Wendel Bruce, Director
- MAXWELL LINDA, Director